Kenji Kubo
- Neurology top 10%
- Neurofibromatosis and Schwannoma Cases 4
- Neurosurgical Procedures and Complications 2
-
- COVID-19 Clinical Research Studies 3
- Viral Infections and Vectors 2
-
- Glioma Diagnosis and Treatment 3
-
- Meningioma and schwannoma management 7
- Sepsis Diagnosis and Treatment 3
-
- Head and Neck Surgical Oncology 3
Kenji Kubo
33 papers receiving 295 citations
Peers
Comparison fields: 5 of 71
- Neurology 96
- Infectious Diseases 77
- Applied Microbiology and Biotechnology 8
- Genetics 38
- Critical Care and Intensive Care Medicine 16
Countries citing papers authored by Kenji Kubo
This map shows the geographic impact of Kenji Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Kubo more than expected).
Fields of papers citing papers by Kenji Kubo
This network shows the impact of papers produced by Kenji Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Kubo. The network helps show where Kenji Kubo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenji Kubo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 58 | |
| 11 | 2019 | 7 | |
| 12 | 2016 | 18 | |
| 13 | 2012 | 8 | |
| 14 | 2006 | 18 | |
| 15 | 2001 | 12 | |
| 16 | 2000 | 15 | |
| 17 | 1999 | 9 | |
| 18 | 1999 | 18 | |
| 19 | 1998 | 0 | |
| 20 | 1991 | 11 |
About Kenji Kubo
Kenji Kubo is a scholar working on Applied Microbiology and Biotechnology, Neurology and Critical Care and Intensive Care Medicine, having authored 37 papers that have together received 308 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (7 papers), Neurofibromatosis and Schwannoma Cases (4 papers), Glioma Diagnosis and Treatment (3 papers), COVID-19 Clinical Research Studies (3 papers), Head and Neck Surgical Oncology (3 papers), Sepsis Diagnosis and Treatment (3 papers), Neurosurgical Procedures and Complications (2 papers) and Viral Infections and Vectors (2 papers). The work is most often cited by research in Neurology (96 citations), Infectious Diseases (77 citations) and Applied Microbiology and Biotechnology (8 citations). Kenji Kubo has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Naoyuki Nakao, Hiroshi Moriwaki, Toru Itakura, Shinichiro Maeshima, Yuji Uematsu, Akihiko Sakata, Yuki Himoto, Hyun‐Jin Kim, Akira Kawamura and Aiko Osawa. Their work appears in journals such as The Journal of Infectious Diseases, Journal of neurosurgery and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.